Your browser doesn't support javascript.
loading
How autoreactive thymocytes differentiate into regulatory versus effector CD4+ T cells after avoiding clonal deletion.
Tai, Xuguang; Indart, Alyssa; Rojano, Mirelle; Guo, Jie; Apenes, Nicolai; Kadakia, Tejas; Craveiro, Marco; Alag, Amala; Etzensperger, Ruth; Badr, Mohamed Elsherif; Zhang, Flora; Zhang, Zhongmei; Mu, Jie; Guinter, Terry; Crossman, Assiatu; Granger, Larry; Sharrow, Susan; Zhou, Xuyu; Singer, Alfred.
Afiliação
  • Tai X; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Indart A; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Rojano M; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Guo J; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Apenes N; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kadakia T; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Craveiro M; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Alag A; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Etzensperger R; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Badr ME; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zhang F; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zhang Z; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Mu J; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Guinter T; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Crossman A; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Granger L; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Sharrow S; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zhou X; Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Singer A; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. singera@mail.nih.gov.
Nat Immunol ; 24(4): 637-651, 2023 04.
Article em En | MEDLINE | ID: mdl-36959291
ABSTRACT
Thymocytes bearing autoreactive T cell receptors (TCRs) are agonist-signaled by TCR/co-stimulatory molecules to either undergo clonal deletion or to differentiate into specialized regulatory T (Treg) or effector T (Teff) CD4+ cells. How these different fates are achieved during development remains poorly understood. We now document that deletion and differentiation are agonist-signaled at different times during thymic selection and that Treg and Teff cells both arise after clonal deletion as alternative lineage fates of agonist-signaled CD4+CD25+ precursors. Disruption of agonist signaling induces CD4+CD25+ precursors to initiate Foxp3 expression and become Treg cells, whereas persistent agonist signaling induces CD4+CD25+ precursors to become IL-2+ Teff cells. Notably, we discovered that transforming growth factor-ß induces Foxp3 expression and promotes Treg cell development by disrupting weaker agonist signals and that Foxp3 expression is not induced by IL-2 except under non-physiological in vivo conditions. Thus, TCR signaling disruption versus persistence is a general mechanism of lineage fate determination in the thymus that directs development of agonist-signaled autoreactive thymocytes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deleção Clonal / Timócitos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deleção Clonal / Timócitos Idioma: En Ano de publicação: 2023 Tipo de documento: Article